Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-30 @ 3:03 PM
Study NCT ID:
NCT07107633
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2025-07-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.
Sponsor:
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-10
First Submit QC Date:
None
Study First Post Date:
2025-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-04
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL